首页> 外文OA文献 >N-glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography-mass spectrometry
【2h】

N-glycosylation site occupancy in serum glycoproteins using multiple reaction monitoring liquid chromatography-mass spectrometry

机译:多重反应监测液相色谱-质谱法测定血清糖蛋白中的N-糖基化位点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Congenital disorders of glycosylation (CDGs) are a family of N-linked glycosylation defects associated with severe clinical manifestations. In CDG type-I, deficiency of lipid-linked oligosaccharide assembly leads to the underoccupancy of N-glycosylation sites on glycoproteins. Although the level of residual glycosylation activity is known to correlate with the clinical phenotype linked to individual CDG mutations, it is not known whether the degree of N-glycosylation site occupancy by itself correlates with the severity of the disease. To quantify the extent of underglycosylation in healthy control and in CDG samples, we developed a quantitative method of N-glycosylation site occupancy based on multiple reaction monitoring LC-MS/MS. Using isotopically labeled standard peptides, we directly quantified the level of N-glycosylation site occupancy on selected serum proteins. In healthy control samples, we determined 98-100% occupancy for all N-glycosylation sites of transferrin and alpha(1)-antitrypsin. In CDG type-I samples, we observed a reduction in N-glycosylation site occupancy that correlated with the severity of the disease. In addition, we noticed a selective underglycosylation of N-glycosylation sites, indicating preferential glycosylation of acceptor sequons of a given glycoprotein. In transferrin, a preferred occupancy for the first N-glycosylation site was observed, and a decreasing preference for the first, third, and second N-glycosylation sites was observed in alpha(1)-antitrypsin. This multiple reaction monitoring LC-MS/MS method can be extended to multiple glycoproteins, thereby enabling a glycoproteomics survey of N-glycosylation site occupancies in biological samples.
机译:先天性糖基化疾病(CDG)是与严重的临床表现相关的N-连锁糖基化缺陷家族。在I型CDG中,脂质连接的寡糖装配不足会导致糖蛋白上N-糖基化位点的占用不足。尽管已知残留糖基化活性的水平与与个别CDG突变相关的临床表型相关,但尚不清楚N-糖基化位点的占用程度本身是否与疾病的严重程度相关。为了量化健康对照和CDG样品中糖基化不足的程度,我们开发了一种基于多重反应监测LC-MS / MS的N-糖基化位点占用的定量方法。使用同位素标记的标准肽,我们可以直接量化所选血清蛋白上N-糖基化位点的水平。在健康的对照样品中,我们确定了转铁蛋白和alpha(1)-抗胰蛋白酶的所有N-糖基化位点的98-100%占用率。在I型CDG样本中,我们观察到与疾病严重程度相关的N-糖基化位点占用减少。另外,我们注意到N-糖基化位点的选择性糖基化不足,表明给定糖蛋白的受体序列的优先糖基化。在转铁蛋白中,观察到第一个N-糖基化位点的优先占有率,并且在α(1)-抗胰蛋白酶中观察到对第一,第三和第二个N-糖基化位点的偏好降低。这种多反应监测LC-MS / MS方法可以扩展到多种糖蛋白,从而可以对生物样品中N-糖基化位点的占有率进行糖蛋白组学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号